
It was the aim of this study to investigate whether leukemia P388 being an important murine transplantation tumor may alter the plasma concentration-time profiles of the alkylating antineoplastic agent bendamustine (1) in mice. In an advanced tumor stage the rapid decline of 1 plasma levels was found to be retarded in tumor-bearing in comparison to tumor-free animals both after i.v. and p.o. drug administration. These changes cannot be explained by the neoplasia-related depression of drug metabolism whereas the 1-containing ascitic fluid may be a possible reason for the prolonged drug levels in plasma. After p.o. administration of 1, the bioavailability of the drug was found to be increased in the leukemia-bearing animals.
Mice, Leukemia P388, Injections, Intravenous, Nitrogen Mustard Compounds, Administration, Oral, Animals, Bendamustine Hydrochloride, Female, Mice, Inbred Strains
Mice, Leukemia P388, Injections, Intravenous, Nitrogen Mustard Compounds, Administration, Oral, Animals, Bendamustine Hydrochloride, Female, Mice, Inbred Strains
| citations The total number of citations received by all articles of the researcher of interest. | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
